SUN-526 Prevalence of Hyperparathyroidism in X-Linked Hypophosphatemia

X-linked hypophosphatemia, due to PHEX mutations results in elevated fibroblast growth factor 23, hypophosphatemia and rickets/osteomalacia. Conventional therapy requires high doses of phosphate salts combined with active vitamin D analogues. Known complications of this regimen include nephrocalcino...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Endocr Soc
Prif Awduron: DeLacey, Sean, Liu, Ziyue, Broyles, Andrea, El-Azab, Sarah, Guandique, Cristian, James, Benjamin, Imel, Erik
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Endocrine Society 2019
Pynciau:
Bone and Mineral Metabolism
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6553120/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-SUN-526
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg